AMT v3 released for beta testing

NEHTA has released a beta version of the Australian Medicines Terminology (AMT) version three, which it says has been designed to simplify version two to make it easier to align with SNOMED CT.

The AMT has been created to align with SNOMED-CT specifications and to describe unique identifiers for generic and brand name medications, their ingredients, dosages and pack sizes. It will be used in clinical information systems for electronic medication management.

The AMT provides standard naming conventions to describe medicines and identifies all commonly used medicines in Australia. It can be implemented in clinical information systems to support prescribing, administration and dispensing, as well as the transfer of information between GP prescribing and community pharmacist dispensing.

The beta version is not ready for clinical use, but has been released for a 10-week review period to SNOMED-CT licence holders. An AMT v3 technical implementation guide is due to be published by the middle of this month.

Feedback is due by April 30 and can be sent to This email address is being protected from spambots. You need JavaScript enabled to view it.

Posted in Australian eHealth

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2017 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.